Table 1. clinical and pathological features of the ACC cohort according to SOX2 expression.
| SOX2negativ | SOX2positiv | p-value | ||
|---|---|---|---|---|
| Age [years] | ≤55 | 13 | 8 | 0.344 |
| >55 | 18 | 6 | ||
| Gender | male | 13 | 5 | 0.693 |
| female | 18 | 9 | ||
| Localization | extra-parotideal | 18 | 12 | 0.069 |
| parotideal | 13 | 2 | ||
| AJCC | I, II III, IV |
13 18 |
10 4 |
0.067 |
| T status | 1+2 | 11 | 8 | 0.173 |
| 3+4 | 20 | 6 | ||
| N status | N0 | 20 | 13 | 0.047 |
| N+ | 11 | 1 | ||
| M status | 0 | 30 | 13 | 0.555 |
| 1 | 1 | 1 | ||
| Progression | no | 20 | 9 | 0.988 |
| yes | 11 | 5 | ||
| Growth pattern | cribrif./tubul./mix. | 19 | 13 | 0.031 |
| solid | 12 | 1 | ||
| Localization of non-solid HNACC | Extra-parotideal | 1 | 4 | 0.015 |
| parotideal | 7 | 1 | ||
Significant p-values (<0.05) are indicated in bold